Table 2 Characteristics of patients with liver-only recurrence
From: Time interval-based indication for liver resection of metastasis from pancreatic cancer
Liver resection | Non-liver resection | P value | ||
|---|---|---|---|---|
(n = 9) | (n = 8) | |||
Age | (years) | 66 (41–74) | 65 (43–74) | 0.97 |
Primary operation | ||||
Pancreaticoduodenectomy | 6 | 4 | ||
Distal pancreatectomy | 3 | 4 | ||
Albumin | (g/dL) | 3.9 (3.5–4.3) | 4.05 (2.4–4.5) | 0.59 |
Serum bilirubin | (μmol/L) | 0.52 (0.25–4.23) | 1.78 (0.33–3.04) | 0.05 |
Prothrombin time (INR) | 0.965 (0.92–1.14) | 0.965 (0.88–1.03) | 0.51 | |
Carcinoembryonic antigen | (IU/L) | 5.1 (1.7–15.2) | 7.8 (2.8–14.5) | 0.21 |
Carbohydrate antigen 19-9 | (IU/L) | 148.8 (15.2–13,820) | 869 (0.1–5210) | 0.99 |
Disease-free interval from pancreatectomy | (months) | 21 (3–44) | 3 (2–7) | 0.02 |
Number of liver metastases | 1 (1–3) | 7 (4–15) | < 0.001 | |
Adjuvant chemotherapy after pancreatectomy | (%) | 4 (44.4) | 2 (25.0) | 0.49 |
Operation time | (min) | 302 (53–413) | N/A | |
Intraoperative blood loss | (mL) | 186 (53–508) | N/A | |
Morbidity (Clavien-Dindo clasification > IIIb) | (%) | 1 (11.1) | N/A | |
Mortality | (%) | 0 | N/A | |